2007
DOI: 10.1111/j.1440-1843.2007.01164.x
|View full text |Cite
|
Sign up to set email alerts
|

Transbronchial needle aspiration accurately diagnoses subcentimetre mediastinal and hilar lymph nodes detected by integrated positron emission tomography and computed tomography

Abstract: PET/CT can identify small malignant lymph nodes that can then be successfully biopsied by TBNA with on-site cytopathology.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
14
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(15 citation statements)
references
References 22 publications
1
14
0
Order By: Relevance
“…Similar results were obtained in four out of seven studies, involving patients with suspected/known lung cancer [20,21,22,25]. The remaining studies reported no significant difference in TBNA sensitivity depending on the lymph node sizes [34,35,36]. The only study performed on patients with suspected sarcoidosis did not detect any significant difference [30].…”
Section: Resultssupporting
confidence: 71%
“…Similar results were obtained in four out of seven studies, involving patients with suspected/known lung cancer [20,21,22,25]. The remaining studies reported no significant difference in TBNA sensitivity depending on the lymph node sizes [34,35,36]. The only study performed on patients with suspected sarcoidosis did not detect any significant difference [30].…”
Section: Resultssupporting
confidence: 71%
“…We observed a survival benefit for pure BAC patients diagnosed according to the WHO classification released in 1999. An earlier hilar-mediastinal recurrence is also detectable by sequential serum carcino-embryonic antigen follow-up and PET/CT-guided transbronchial needle aspiration [13]. Clinical trials have demonstrated patients with pure BAC disproportionately respond to EGFR-TKIs [37].…”
Section: Discussionmentioning
confidence: 97%
“…All suspicious N2 and/or N3 lymph nodes (maximum standardized uptake value ≥2.5 on integrated positron emission tomography and computed tomography, PET/CT or ≥1 cm on the shorter axis on computed tomography, CT) with a clinically relevant impact on cancer management were biopsied. Mediastinoscopy and/or transbronchial needle aspiration were used to biopsy different nodal stations as previously described [13]. All suspicious metastatic (M1) sites determined by PET/CT or CT was also investigated and/or biopsied.…”
Section: Stagingmentioning
confidence: 99%
“…There are studies with results suggesting increased DY of C-TBNA with higher SUVmax on PET/CT, but these studies define diverse range of SUVmax cut-offs such as 2.5, 3 and 5 (15)(16)(17). In this study, a limited percentage of patients (34.9%) had undergone PET/CT.…”
Section: Discussionmentioning
confidence: 99%